Kelly Qiao
Senior Principal·B Capital
Kelly Qiao is a Senior Principal at B Capital, where she leads healthcare investments across Asia. She focuses on biotech, medtech and digital health, and has invested in or served on boards of companies including Insilico Medicine, ProfoundBio, Grit Biotechnology, Rona Therapeutics, Vivacta Bio, Spectrumedics Medical, Macrolux Medical and AlphaLife Sciences. Before B Capital, she worked in healthcare investing and operations, including Managing Director for global healthcare investment at Fosun and Executive Director at Vertex Ventures, after earlier roles at GlaxoSmithKline and Roche.
See the rest of Kelly Qiao's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.